MedCision

MedCision CEO Rolf Ehrhardt, along with representatives from TrakCel, Adaptimmune, Cellex and TiGenix, will be participating in a panelist discussion on alleviating the impact of costly, time consuming cell therapy supply chains on industry, payer and patient alike. Don't miss this special programming at Cell and Gene Therapy Europe on Thursday at 16:05.

ThawSTAR® CB Automated Cryobag Thawing System at Summit

We will be attending CAR-TCR Summit 2017 next week in Boston. Enjoy this short interview with our Chief Commercial Officer, Sam Kent, where he discusses last year's experience. Attending the show this year? Stop by Booth 29 or view our poster presentation at Space #2.

Video - 7960 - CAR-TCR Summit Introducing: CAR-TCR Interview Shorts Series The next in the CAR-TCR Summit Interview Shorts Series is an interview with Samuel Kent, SVP, Business...

We are pleased to be featured in RegMedNet's Spotlight on Commercialization and Translation. Read about ThawSTAR and the science of cell thawing in Brave new world: Automation, thawing, and connectivity will drive the success of cellular therapy https://goo.gl/EBae61

Brave new world: Automation, thawing, and connectivity will drive the success of cellular therapy Controlled automated thawing of therapeutic cells is important to ensuring their optimal viability, recovery, as well as safeguarding cell health...